Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Alex Rae-Grant is a Board Certified Staff Neurologist at the Cleveland Clinic. His areas of expertise are in multiple sclerosis and dementia. He is involved in many educational activities at the Clinic and regionally. He has written a number of text books in neurology and multiple sclerosis.
He joined the staff at the Neurological Institute in 2007 and works at the Mellen Center for MS as well as at the Lou Ruvo Center for Brain Health. At the Mellen Center he directs educational efforts including website management, newly diagnosed classes, regional and national conferences, and patient education material development. He is active in clinical trials in the treatment of MS with the Experimental therapeutics program at the Mellen Center. He also directs the Center for Brain Health at the main Cleveland Clinic campus and is developing clinical trials aimed at early and prodromal Alzheimer's disease at the Mellen Center Campus.
He has written two textbooks of neurology "Neurology for the House Officer" and "Comprehensive Review in Clinical Neurology A Multiple Choice Question Book for the Wards and Boards", and co-edited another textbook of neurology "The 5 minute consult in Neurology". He has co authored a text book on Multiple Sclerosis with Dr. Jeffrey Cohen titled "Handbook of Multiple Sclerosis". He is active in neurology resident education and medical student education and co-directs the neurosciences clerkship at the Cleveland Clinic. He directs a course on critical assessment of the medical literature for the neurology residency at the Cleveland Clinic. In 2009 he was honored as the Teacher of the Year for the neurology program at the Cleveland Clinic. He serves on the Guideline Development Committee of the American Academy of Neurology which develops critical guidelines for patient care in neurology.
He is presently working with a group researching vascular theories of MS using ultrasound, magnetic resonance venography, and pathological anatomy which is supported by the National Multiple Sclerosis society.
multiple sclerosis, Devic's disease, memory impairment, memory loss, mild cognitive impairment, neuroimmunology, neurocognitive disorders including Alzheimer's disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Rae-Grant's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.